ADA 2021: After strong showing for Soliqua against premixed insulin, Sanofi exec expects ‘a lot of interest’ among doctors

ADA 2021: After strong showing for Soliqua against premixed insulin, Sanofi exec expects ‘a lot of interest’ among doctors
esagonowsky
Mon, 06/28/2021 – 08:24